Balancing outcomes and costs for best value in psoriasis

J Eur Acad Dermatol Venereol. 2024 May;38(5):788-789. doi: 10.1111/jdv.19951.

Authors

Jo L W Lambert¹, Filip Roodhooft^{2

3}

Affiliations

¹ Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
² Faculty of Economics and Business, Catholic University of Leuven, Leuven, Belgium.
³ Vlerick Business School, Ghent, Belgium.

PMID: 38661013
DOI: 10.1111/jdv.19951

No abstract available

Publication types

Editorial
Letter

MeSH terms

Cost-Benefit Analysis
Humans
Psoriasis* / economics